News

‘Real-World Evidence Mythbusting’ in Clinical Trials Innovation

An Unforgettable First SCDM Experience in Seattle

uMotif nominated for OBN award

uMotif secures £2.4 million funding – led by Albion Capital

uMotif delighted to announce Willie Muehlhausen, eCOA subject matter expert, as member of advisory board

We are growing across uMotif and are looking for people who want to join our team

uMotif attending SCDM 2018 Annual Conference in Seattle

Guardian Article: The app that could save lives by speeding up drug trials

Our employee interview series continues with a technology focus